Effects of Oral Procaterol for Postinfectious Cough in Adults: SingleCentre, Randomized Double-Blind, Placebo-Controlled Trial
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Persistent cough following an upper respiratory tract infection (URTI) is common in clinical practice. We investigated the effects of procaterol on cough-specific quality of life (QoL) and peripheral-airway function among adults suffering from postinfectious cough (PIC). Methods: This was a prospective, randomized, double-blinded placebo-controlled trial (NCT 02349919) conducted at a university hospital. Seventy-four non-asthmatic adults who had persistent post-URTI cough for ≥3 weeks were assessed by a physical examination, chest/paranasal sinus radiographs, spirometry, and impulse oscillometry (IOS) and were allocated to receive procaterol or placebo for 4 weeks. The Thai version of the Leicester Cough Questionnaire (LCQ-T), spirometry and IOS were assessed at baseline, 2 weeks, and 4 weeks. Results: Mean LCQ-T total scores for the procaterol group (10.8) and placebo group (10.9) at baseline were not significantly different (P=0.821). After adjustment for baseline Borg Cough Scale score and post-nasal drip, the mean between-group difference was not significant for LCQ-T total score (-1.26; 95% confidence interval [CI], -2.69 to 0.17), physical domain score (-0.35; 95% CI, -0.76 to 0.06), psychological domain score (-0.53; 95% CI, -1.06 to 0.01), or social domain score (-0.38; 95% CI, -0.92 to 0.16). Large improvements in LCQ-T total score were reported in both groups after 2 weeks (procaterol, 4.21±2.73; placebo, 5.34±3.2), and 4 weeks (procaterol, 5.94±3.68; placebo, 7.07±3.44). No differences between groups were found in the mean changes of spirometry or IOS parameters after 4 weeks. Conclusion: Our study shows that procaterol is not effective in the treatment of PIC, in terms of improvement of cough-specific QoL or peripheral-airway function.
Abstract
Background: Persistent cough following an upper respiratory tract infection (URTI) is common in clinical practice. We investigated the effects of procaterol on cough-specific quality of life (QoL) and peripheral-airway function among adults suffering from postinfectious cough (PIC). Methods: This was a prospective, randomized, double-blinded placebo-controlled trial (NCT 02349919) conducted at a university hospital. Seventy-four non-asthmatic adults who had persistent post-URTI cough for ≥3 weeks were assessed by a physical examination, chest/paranasal sinus radiographs, spirometry, and impulse oscillometry (IOS) and were allocated to receive procaterol or placebo for 4 weeks. The Thai version of the Leicester Cough Questionnaire (LCQ-T), spirometry and IOS were assessed at baseline, 2 weeks, and 4 weeks. Results: Mean LCQ-T total scores for the procaterol group (10.8) and placebo group (10.9) at baseline were not significantly different (P=0.821). After adjustment for baseline Borg Cough Scale score and post-nasal drip, the mean between-group difference was not significant for LCQ-T total score (-1.26; 95% confidence interval [CI], -2.69 to 0.17), physical domain score (-0.35; 95% CI, -0.76 to 0.06), psychological domain score (-0.53; 95% CI, -1.06 to 0.01), or social domain score (-0.38; 95% CI, -0.92 to 0.16). Large improvements in LCQ-T total score were reported in both groups after 2 weeks (procaterol, 4.21±2.73; placebo, 5.34±3.2), and 4 weeks (procaterol, 5.94±3.68; placebo, 7.07±3.44). No differences between groups were found in the mean changes of spirometry or IOS parameters after 4 weeks. Conclusion: Our study shows that procaterol is not effective in the treatment of PIC, in terms of improvement of cough-specific QoL or peripheral-airway function.
참고문헌 (30)
- Hegele RG, "Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections", Am J Respir Crit Care Med, 151, pp.1659~1664 (1995)
- Blair HT, "Effects of rhinovirus infection of pulmonary function of healthy human volunteers", Am Rev Respir Dis, 114, pp.95~102 (1976)
- Empey DW, "Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection", Am Rev Respir Dis, 113, pp.131~139 (1976)
- Borson DB, "Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections", J Appl Physiol (1985), 66, pp.2653~2658 (1989)
- Busse WW, "Effect of influenza A virus on leukocyte histamine release", J Allergy Clin Immunol, 71, pp.382~388 (1983)
- Chonmaitree T, "Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes:a possible role in the mechanism of virus-induced asthma", J Infect Dis, 164, pp.592~594 (1991)
- Ida S, "Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon", J Exp Med, 145, pp.892~906 (1977)
- Volovitz B, "Release of leukotriene C4 in respiratory tract during acute viral infection", J Pediatrw, 112, pp.218~222 (1988)
- O’Connell F, "Capsaicin cough sensitivity increases during upper respiratory infection", Respir Med, 90, pp.279~286 (1996)
- Salem H, "Antitussive drugs, with special reference to a new theory for the initation of the cough reflex and the influence or bronchodilators", Am J Med Sci, 247, pp.585~600 (1964)
- Hueston WJ, "A comparison of albuterol and erythromycin for the treatment of acute bronchitis", J Fam Pract, 33, pp.476~480 (1991)
- Frank A, "Inhaled beclomethasone dipropionate in acute infections of the respiratory tract", Respiration, 48, pp.122~126 (1985)
- Pornsuriyasak P, "Inhaled corticosteroid for persistent cough following upper respiratory tract infection", Respirology, 10, pp.520~524 (2005)
- Holmes PW, "Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection", Respir Med, 86, pp.425~429 (1992)
- Birring SS, "Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)", Thorax, 58, pp.339~343 (2003)
- Pornsuriyasak P, "Validity and reliability of the Thai version of the leicester cough questionnaire in chronic cough", Asian Pac J Allergy Immunol, 34, pp.212~216 (2016)
- Pornsuriyasak P, "Minimal clinically important differences (MCIDs) of the thai version of the leicester cough questionnaire for subacute and chronic cough", Value Health Reg Issues, 12, pp.57~62 (2017)
- Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999:this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
- Suzuki H, "Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan", United European Gastroenterol J, 1, pp.175~183 (2013)
- Jirarattanaphochai K, "Reliability of the medical outcomes study short-form survey version 2.0(Thai version) for the evaluation of low back pain patients", J Med Assoc Thai, 88, pp.1355~1361 (2005)
- Oostveen E, "The forced oscillation technique in clinical practice: methodology, recommendations and future developments", Eur Respir J, 22, pp.1026~1041 (2003)
- Dicpinigaitis PV, "Effect of viral upper respiratory tract infection on the urge-to-cough sensation", Respir Med, 105, pp.615~618 (2011)
- Taramarcaz P, "Transient postviral vocal cord dysfunction", J Allergy Clin Immunol, 114, pp.1471~1472 (2004)
- Dicpinigaitis PV, "Effect of viral upper respiratory tract infection on cough reflex sensitivity", J Thorac Dis, 6, pp.S708~S711 (2014)
- Tashimo H, "Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness", Allergol Int, 56, pp.241~247 (2007)
- Sekizawa K, "Role of substance P in cough during bronchoconstriction in awake guinea pigs", Am J Respir Crit Care Med, 151, pp.815~821 (1995)
- Fujimura M, "Effect of inhaled procaterol on cough receptor sensitivity to capsaicin in patients with asthma or chronic bronchitis and in normal subjects", Thorax, 48, pp.615~618 (1993)
- Tomerak AA, "Inhaled beta2-agonists for treating non-specific chronic cough in children", Cochrane Database Syst Rev, pp.CD005373~ (2005)
- Wang K, "Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in England: a retrospective analysis", Pediatr Infect Dis J, 30, pp.1047~1051 (2011)
- Ryan NM, "Clinical and physiological features of postinfectious chronic cough associated with H1N1 infection", Respir Med, 106, pp.138~144 (2012)
